NASDAQ$VTRS
Viatris Inc · Q1 2026 earnings
Q1 2026 earnings · · Investor relations
Briefing
Viatris reported Q1 2026 total revenues of $3.52B (+8% YoY) with net earnings of $176.4M and diluted EPS of $0.15.
For the quarter ended March 31, 2026, Viatris reported total revenues of $3.52 billion versus $3.25 billion a year ago. Net earnings were $176.4 million, or $0.15 per diluted share, compared with a net loss of $3.04 billion, or $(2.55) per share, in Q1 2025 which included large one-time charges. Loss from operations was $79.7 million after restructuring and manufacturing charges.
- Total revenues $3.52B (+8% YoY).
- Net earnings $176.4M; diluted EPS $0.15 vs $(2.55).
- Restructuring and Indore/Nashik manufacturing charges.
- Closed Biocon Biologics stake sale for $815M consideration.
Headline financials
Revenue & EPS history
Viatris · Revenue · Quarterly
$3.52B
Revenue by segment
Viatris · $2.44B total across 1 segment · Q2 2023
- Brands$2.44B-1.5%100.0%
Forward guidance
Management discusses 2026 restructuring program ($600–700M savings target) and pipeline; detailed guidance in annual materials.
Tailwinds
- Revenue growth and return to net earnings.
- Strategic divestitures and cost program.
Headwinds
- Operating loss before one-times.
- FDA import alert and India manufacturing disruptions.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2026
+0.3%
Avg return
Earnings day
+0.5%
Avg return
5 days after
-1.2%
Avg return
30 days after
52%
26 / 50 earnings
Positive
+14.4%
Q3 2022
Best reaction
-30.2%
Q4 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +11.3% | +9.1% | +3.0% | |
| Q4 2025 | -4.3% | -7.4% | -18.8% | |
| Q3 2025 | -6.5% | +4.2% | +1.7% | |
| Q1 2025 | +5.8% | +2.2% | +1.3% | |
| Q4 2024 | -15.2% | -16.6% | -22.8% | |
| Q3 2024 | +11.6% | +11.4% | +9.6% | |
| Q2 2024 | +3.7% | +1.8% | -0.8% | |
| Q1 2024 | -5.5% | -5.7% | -11.3% | |
| Q4 2023 | -6.5% | -6.6% | -9.8% | |
| Q3 2023 | +0.1% | -0.1% | +6.0% | |
| Q2 2023 | +5.3% | +7.2% | -4.4% | |
| Q1 2023 | +5.0% | +0.0% | +4.6% | |
| Q4 2022 | -1.0% | -3.3% | -17.2% | |
| Q3 2022 | +14.4% | +17.9% | +12.4% | |
| Q2 2022 | +7.5% | +14.4% | -0.1% | |
| Q1 2022 | +5.1% | +11.4% | +19.2% | |
| Q4 2021 | -30.2% | -29.8% | -24.4% | |
| Q3 2021 | +6.1% | +2.8% | -9.5% | |
| Q2 2021 | +6.0% | +4.9% | +2.1% | |
| Q1 2021 | +7.5% | +13.6% | +9.7% | |
| Q4 2018 | -3.8% | -6.3% | -5.9% | |
| Q4 2020 | -3.8% | -18.5% | -23.1% | |
| Q3 2020 | +3.8% | +2.8% | +17.0% | |
| Q2 2020 | -3.0% | -2.3% | -7.9% | |
| Q1 2020 | +4.2% | -3.7% | +4.8% | |
| Q4 2019 | +4.2% | -3.7% | +4.8% | |
| Q3 2019 | +2.5% | -2.0% | +1.6% | |
| Q2 2019 | +2.1% | +3.4% | +9.1% | |
| Q1 2019 | +0.5% | -3.2% | -3.8% | |
| Q3 2018 | -0.3% | -1.6% | -14.8% | |
| Q2 2018 | +0.8% | -1.0% | -0.3% | |
| Q1 2018 | -4.0% | -0.9% | -4.4% | |
| Q4 2017 | +1.9% | +4.7% | +8.7% | |
| Q3 2017 | +5.0% | +22.5% | +24.3% | |
| Q2 2017 | -0.6% | -0.7% | -0.8% | |
| Q1 2017 | -3.4% | -4.1% | -7.4% | |
| Q4 2016 | +4.6% | +6.0% | -1.9% | |
| Q3 2016 | -5.2% | -5.6% | -7.5% | |
| Q2 2016 | +1.0% | +1.5% | +9.3% | |
| Q1 2016 | -1.4% | — | — | |
| Q4 2015 | -2.2% | — | — | |
| Q3 2015 | -1.5% | — | — | |
| Q2 2015 | -1.7% | — | — | |
| Q1 2015 | -3.7% | — | — | |
| Q4 2014 | -2.3% | — | — | |
| Q3 2014 | -1.7% | — | — | |
| Q2 2014 | +0.1% | — | — | |
| Q1 2014 | +0.0% | — | — | |
| Q4 2013 | +1.4% | — | — | |
| Q3 2013 | -0.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro